You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Singapore

Jun 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Strong growth for consumer health

In 2011 consumer health in Singapore increased faster than in 2010, driven by increasing awareness of consumer health products, as well as more product launches. This was consistent through product categories, but particularly evident in weight management and vitamins and dietary supplements, signifying greater attention paid to the prevention of illness and the maintenance of wellbeing, in addition to the treatment of health conditions.

Paediatric consumer health increases as the birth rate increases

Sales of paediatric consumer health products increased in 2011. Consumers spent more and traded up to better-quality products for their children. Companies responded by continuing to launch differentiated products for children. With the Chinese lunar year of the Dragon in 2012, an expected spike in childbirth is expected, increasing the demand for paediatric consumer health products.

Race for innovation in order for companies to lead and retain market share

2011 saw several new products based on technological breakthroughs, such as GlaxoSmithKline Singapore’s Panadol Actifast and Beiersdorf ’s Hansaplast Fast Healing plasters. Greater and faster efficacy is driving purchasing decisions, as consumers are willing to switch brands and pay more for faster-acting results.

Health and beauty retailers stay as the main key channels

Health and beauty retailers which is mainly comprises of chemist/pharmacist and drugstores/parapharmacies remains as the key channel for consumer health in Singapore in 2011. Consumers are already accustomed to visit such shops as this channel is widely available and offer wider range of consumer health products. Nonetheless, other healthcare specialist which includes GNC, Nature Farms shows strong performance in 2011 due to increasing health awareness for healthy lifestyle prevention as well increasing store presence across Singapore.

Consumers become more astute about product information

Consumers are expected to become more astute when it comes to product information in the forecast period. More people are becoming aware that claims such as “organic” and “natural” are sometimes loosely applied, and – with wider availability of information – are starting to take it upon themselves to verify such claims. In the forecast period, overall consumer health is projected to see positive and faster growth compared with the review period.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Singapore with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Singapore, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Singapore for free:

The Consumer Health in Singapore market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Singapore?
  • What are the major brands in Singapore?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Singapore - Industry Overview

EXECUTIVE SUMMARY

Strong growth for consumer health

Paediatric consumer health increases as the birth rate increases

Race for innovation in order for companies to lead and retain market share

Health and beauty retailers stay as the main key channels

Consumers become more astute about product information

KEY TRENDS AND DEVELOPMENTS

Companies build brand equity through a high rate of innovation

Paediatric consumer health grows despite the low birth rate

Internet retailing sees steady growth, whilst direct selling loses share

Wellness services make a dual impact on consumer health

Increase in physical exercise and nutrition shape demand for consumer health

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Penetration of Private Label by Category 2006-2011
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC - Switches 2009-2011

SOURCES

  • Summary 2 Research Sources

Consumer Health in Singapore - Company Profiles

Best World International Ltd in Consumer Health (Singapore)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Best World International Ltd: Competitive Position 2011

Cerebos Pacific Ltd in Consumer Health (Singapore)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Cerebos Pacific Ltd: Competitive Position 2011

Eu Yan Sang (S) Pte Ltd in Consumer Health (Singapore)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 11 Eu Yan Sang (S) Pte Ltd: Competitive Position 2011

Haw Par Healthcare Ltd in Consumer Health (Singapore)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 14 Haw Par Healthcare Ltd: Competitive Position 2011

Hoe Pharmaceuticals Sdn Bhd in Consumer Health (Singapore)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 16 Hoe Pharmaceuticals Sdn Bhd: Competitive Position 2011

Adult Mouth Care in Singapore - Category Analysis

HEADLINES

TRENDS

  • Outbreaks of hand, foot and mouth disease (HFMD) continued to occur in 2011, with more than 4,000 cases in the first half of the year alone. Usually striking children, adult care-givers are also at risk of contracting the disease, resulting in an increase in value sales of adult mouth care products.

SWITCHES

COMPETITIVE LANDSCAPE

  • In adult mouth care, steady positive growth was enjoyed by most players in 2011, with the major companies maintaining their positions. This was due to strong brand equity in a relatively small category, in which consumers tend to recognise few key brands.

PROSPECTS

  • A constant value CAGR of 2% is expected for adult mouth care in the forecast period. Children population is projected to increase due to the expected birth rates increase due to the dragon year in 2012. Thus, coupled with continuous self-medication trend among consumers as well as parents for their children, this lead to positive growth in the forecast period.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2006-2011
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 14 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 15 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Singapore - Category Analysis

HEADLINES

TRENDS

  • Analgesics increased by 6% in 2011, reaching S$38 million. Compared with 2010, when analgesics saw 5% growth, this positive growth in 2011 was reflective of buoyant consumer demand, new product launches and aggressive marketing and advertising. The 2011 growth rate also exceeded the CAGR of 5% in the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • Whilst GlaxoSmithKline Singapore led analgesics in 2011, the company continued to lose share. It accounted for 36% of value sales in 2011, compared with 39% in 2006. Its leading position was nonetheless maintained by the popular and heavily advertised Panadol range of products. Panadol consistently launched sub-brands such as Panadol Actifast and Panaflex to garner new consumer demand.

PROSPECTS

  • Analgesics is expected to see a constant value CAGR of 2% in the forecast period. As consumers’ awareness increases, they are likely to adopt a more holistic approach to pain management, rather than just relying on drugs.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2006-2011
  • Table 19 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 21 Analgesics Company Shares by Value 2007-2011
  • Table 22 Analgesics Brand Shares by Value 2008-2011
  • Table 23 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Singapore - Category Analysis

HEADLINES

TRENDS

  • Melatonin is the most popular ingredient which consumers look for in calming and sleeping products. The hormone is widely believed to be an effective yet non-disruptive alternative to prescription medication for insomnia. With increasingly fast-paced lifestyles resulting in fewer hours of rest, more people were turning to melatonin as a first foray into sleep medication.

SWITCHES

COMPETITIVE LANDSCAPE

  • 21st Century Healthcare with its brand 21st Century Melatonin enjoyed a 6% increase in value sales in 2011. It has extensive distribution across the country, strong brand equity, and often has its own shelves of products in retail shops. The company held a 24% value share in calming and sleeping in 2011.

PROSPECTS

  • Calming and sleeping is expected to see a constant value CAGR of 1% in the forecast period. Unless new research shows new ingredients to have a positive effect on sleep, OTC products for calming and sleeping are likely to continue to focus on melatonin as a key ingredient.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2006-2011
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 27 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 28 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Singapore - Category Analysis

HEADLINES

TRENDS

  • Singapore experienced a flu epidemic in the early months of 2011, resulting in record cases of acute upper respiratory illnesses. The Ministry of Health reported that influenza cases (as seen at public polyclinics) increased by more than 10% in the month of January 2011 alone (from 16,630 to 18,377 cases).

SWITCHES

COMPETITIVE LANDSCAPE

  • Ricola, known for its range of herbal sweets, was the most popular brand in cough, cold and allergy remedies in 2011, and also had key launches. During the year it launched a number of new flavours, such as Honey Herb, Mixed Berry and Orange Mint, and it launched new Ricola Dual Action Cough Drops, which combat both coughs and sore throats.

PROSPECTS

  • Cough, cold and allergy remedies is expected to post a moderate constant value CAGR of 1% in the forecast period.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 33 Sales of Decongestants by Category: Value 2006-2011
  • Table 34 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 35 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 36 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Singapore - Category Analysis

HEADLINES

TRENDS

  • Singapore continued to see an increase in foodservice outlets in 2011, spurring consumer expenditure on meals at restaurants. Whilst there was increased awareness of the negative effects of overeating, consumers were nonetheless tempted by value for money restaurant deals.

SWITCHES

COMPETITIVE LANDSCAPE

  • Po Chai, Eno and Dulcolax were the three brands which led digestive remedies in 2011. Consumers perceive these as established and effective remedies, and are less likely to switch to brands which are unfamiliar.

PROSPECTS

  • Digestive remedies is projected to be still growing with less than 1% constant value CAGR in forecast period. The slow growth is expected due to the maturity of the products and the main drivers for the growth was population growth as well as value added products innovation in forecast period.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 43 Digestive Remedies Company Shares by Value 2007-2011
  • Table 44 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Singapore - Category Analysis

HEADLINES

TRENDS

  • Ear care continued to be a relatively small category in 2011. Consumers have limited choices in terms of brands, and also limited channels for purchasing such products. Limited choice in turn creates low awareness of ear care products, limiting potential demand amongst consumers who choose from what is available.

SWITCHES

COMPETITIVE LANDSCAPE

  • The continued lack of availability of Earex from SSL Healthcare Singapore meant the absence of a strong contender for leader Tropex by Rowa Pharmaceuticals. Rowa Pharmaceuticals increased its value share to 57% in ear care in 2011.

PROSPECTS

  • Ear care is expected to see a constant value CAGR of 1% in the forecast period. Consumers are expected to be increasingly more aware on such products with the wide availability of pharmacists across Singapore to advice on such treatment which lead to higher rate of self medication in forecast period.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2006-2011
  • Table 48 Sales of Ear Care: % Value Growth 2006-2011
  • Table 49 Ear Care Company Shares by Value 2007-2011
  • Table 50 Ear Care Brand Shares by Value 2008-2011
  • Table 51 Forecast Sales of Ear Care: Value 2011-2016
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2011-2016

Eye Care in Singapore - Category Analysis

HEADLINES

TRENDS

  • Eye care saw a better performance in 2011, growing by 5% in current value terms, compared with 4% growth in 2010. An ageing population and increased sensitivity to pollutants saw consumers purchasing more products for conditions such as dry eye and mild eye allergies. The rise in the popularity of contact lenses and their misuse also contributed to the higher sales of eye care products.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline Singapore maintained its lead in eye care with a 46% value share in 2011. Its familiar brand Eye Mo reached sales of S$2 million in 2011; almost twice as much as its closest competitor, Optrex by Reckitt Benckiser.

PROSPECTS

  • Eye care is expected to post a constant value CAGR of 3% in the forecast period. As Singapore’s population continues to age, demand for standard eye care products is expected to continue to increase.

CATEGORY DATA

  • Table 53 Sales of Eye Care by Category: Value 2006-2011
  • Table 54 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 55 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 56 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 57 Eye Care Company Shares by Value 2007-2011
  • Table 58 Eye Care Brand Shares by Value 2008-2011
  • Table 59 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 60 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Singapore - Category Analysis

HEADLINES

TRENDS

  • In 2011, companies manufacturing and retailing herbal/traditional products strongly highlighted the natural ingredients of products to appeal to consumers who were increasingly wary of the side-effects of standard products. Increasingly, companies also refreshed their brands of herbal/traditional products, updating their image to appeal to a younger audience.

COMPETITIVE LANDSCAPE

  • Cerebos Pacific led herbal/traditional products in 2011 with an 8% value share. Its Brand’s line is widely available, and is commonly used as both a restorative, and to perk up tired minds. It launched a series of new ranges over the review period, such as Innershine featuring antioxidants and AlphaMynd for children, “for healthy brain function”. It also ran successful lucky draws and contests, as well as advertising campaigns, and continued to harness social media to reach out to new audiences, particularly young adults.

PROSPECTS

  • A constant value CAGR of 1% is expected for herbal/traditional products in the forecast period. This takes into account the growing popularity of herbal/traditional products, and also companies being likely to jump on the bandwagon by adding “natural” and “organic” ingredients to their products to attract growing demand.

CATEGORY DATA

  • Table 61 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 62 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 63 Herbal/Traditional Products Company Shares 2007-2011
  • Table 64 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 65 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 66 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Singapore - Category Analysis

HEADLINES

TRENDS

  • In 2011 medicated skin care fared better compared with 2010. Products such as Dettol experienced high value growth in 2011 due to strong brand loyalty and the perceived positive health benefits of these products. Antifungal products such as Daktarin also saw a significant increase in demand; the increased participation in sport in Singapore’s humid weather can be said to be a factor in this regard.

SWITCHES

COMPETITIVE LANDSCAPE

  • Reckitt Benckiser was the leading player in medicated skin care in 2011, accounting for a 42% share of overall value sales. Its Dettol brand alone held a strong share of 80% within topical germicidals/antiseptics in 2011, accounting for sales of S$8 million.

PROSPECTS

  • Medicated skin care is projected to see a modest constant value CAGR of 1% in the forecast period. The main driver for medicated skin care will be mainly coming from the topical germicidals/antiseptic products as consumers are expected to keep its hygiene in their homes, particularly when they have toddler. Thus, coupled with value added product innovation, this will sustain the overall medicated skin care to be in positive in forecast period.

CATEGORY DATA

  • Table 67 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 68 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 69 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 70 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 71 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 72 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 73 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Singapore - Category Analysis

HEADLINES

TRENDS

  • According to the latest national health survey, Singapore saw an increase in the number of smokers, particularly amongst young adults and underage youths. This was despite aggressive public health campaigns and the increased implementation of smoking bans and fines in public areas.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson accounted for a 66% share of value sales in NRT smoking cessation aids in 2011, with sales of S$1 million. It also saw the highest growth of 5% in 2011. The company’s Nicorette brand has all three formats which are permissible for sale in Singapore – gum, inhalators and patches – and these are widely available, which helped to boost sales. The next biggest competitor, Novartis Consumer Health, only has the gum and patch formats available under its Nicotinell brand.

PROSPECTS

  • NRT smoking cessation aids is likely to see an increase in 2012, as the Singaporean government steps up anti-smoking measures. For example, it plans to extend the existing smoking ban to include more public areas. Higher taxation will also hit products such as hand-rolling tobacco leaves and beedi (a type of cigarette which is popular in South Asia, tied together in a leaf), which currently have lower tax compared with cigarettes. All these factors may lead to an increase in the number of people who decide to try and quit the habit.

CATEGORY INDICATORS

  • Table 74 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 75 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 76 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 77 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 78 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 79 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 80 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 81 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Singapore - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition grew by a healthy 6% in current value terms in 2011, with sales reaching S$7 million. Membership of fitness centres was reported to have grown significantly, with some chains seeing a 100% increase in new members in the year. Residents were also turning to high impact endurance training to take part in sporting events such as triathlons, as seen from rising participation in such events.

COMPETITIVE LANDSCAPE

  • General Nutrition Centers led sports nutrition in 2011 with a 60% share of value sales. It has an extensive range of GNC products, from powders to shakes and bars, in a wide variety of flavours.

PROSPECTS

  • Sports nutrition is expected to see a constant value CAGR of 5% in the forecast period. Sports nutrition is expected to see further growth as more people start to exercise regularly and pay attention to their physique. The high value growth of protein powder is expected to fuel growth in the overall category as protein powder is the biggest bulk of sport nutrition.

CATEGORY DATA

  • Table 82 Sales of Sports Nutrition: Value 2006-2011
  • Table 83 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 84 Sports Nutrition Company Shares 2007-2011
  • Table 85 Sports Nutrition Brand Shares 2008-2011
  • Table 86 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 87 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Singapore - Category Analysis

HEADLINES

TRENDS

  • More Singaporean consumers are taking vitamins and dietary supplements as part of their daily routine. These are widely believed to boost immunity and improve wellbeing, and are often consumed to compensate for a less than ideal diet as a result of the hectic pace of life. In addition, whilst HSA guidelines stipulate that vitamins and dietary supplements cannot claim to cure ailments, consumers do tend to associate certain products with boosting the alleviation of common ailments, such as colds and the flu.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Cerebos Pacific, General Nutrition Centers and Amway led vitamins and dietary supplements in 2011. These three companies accounted for a combined 16% share of value sales, and were leaders due to their wide distribution networks, strong marketing and brand equity, as well as attractive membership privileges. For instance, there are close to 60 GNC outlets in Singapore.

PROSPECTS

  • Vitamins and dietary supplements is expected to see a constant value CAGR of 1% in the forecast period. The constant value sales growth is expected to slow down due to some of the product such as tonics and bottled nutritive drinks, combination dietary products, vitamins are in mature stage.

CATEGORY DATA

  • Table 88 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 89 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 90 Dietary Supplements by Positioning 2006-2011
  • Table 91 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 92 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 93 Vitamins Brand Shares by Value 2008-2011
  • Table 94 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 95 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 96 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016
  • Summary 17 Dietary Supplements: Brand Ranking by Positioning 2011

Weight Management in Singapore - Category Analysis

HEADLINES

TRENDS

  • Demand for weight management products saw a healthy increase in 2011. Total sales reached S$38 million, despite few new launches. Consumers supported established, trusted brands, and were particularly inclined towards meal replacement slimming amongst the wide range of products available for weight management.

COMPETITIVE LANDSCAPE

  • Herbalife International Singapore led weight management in 2011. It held a 52% share of value sales with its eponymous brand with an extensive range of products, from meal supplements to slimming products. It has a strong distribution network which focuses on direct selling.

PROSPECTS

  • A negligible positive constant value CAGR is predicted for weight management in the forecast period. In addition to rising demand for natural ingredients, consumers are likely to seek out more holistic solutions to weight management, and look for products which back up efficacy claims with statistics and scientific evidence.

CATEGORY DATA

  • Table 97 Sales of Weight Management: Value 2006-2011
  • Table 98 Sales of Weight Management: % Value Growth 2006-2011
  • Table 99 Weight Management Company Shares 2007-2011
  • Table 100 Weight Management Brand Shares 2008-2011
  • Table 101 Forecast Sales of Weight Management: Value 2011-2016
  • Table 102 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Singapore - Category Analysis

HEADLINES

TRENDS

  • In wound care, new product features such as film-forming gels, moisture-retaining plasters, anti-scarring and fast-healing properties continued to emerge. The rise in such value-added products led to higher value sales of wound care products, whilst greater awareness of work safety and increased overseas travel led to growth in first aid items.

COMPETITIVE LANDSCAPE

  • Beiersdorf led wound care in 2011 with a value share of 40%. It is one of the biggest manufacturers of sticking plasters/adhesive bandages, thanks to its popular Hansaplast brand.

PROSPECTS

  • Wound care is expected to see a constant value CAGR of 1% in the forecast period. Population increase as well as increasing consumer habit to cover their wound is projected to be the main driver for such products. In addition, value added product innovation such as faster healing and anti-scarring are also projected to drive the constant value growth in forecast period.

CATEGORY DATA

  • Table 103 Sales of Wound Care by Category: Value 2006-2011
  • Table 104 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 105 Wound Care Company Shares by Value 2007-2011
  • Table 106 Wound Care Brand Shares by Value 2008-2011
  • Table 107 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 108 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Celery
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Lecithin
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!